Sunshine Biopharma (SBFM) Treasury Shares (2022 - 2023)

Sunshine Biopharma (SBFM) reported Treasury Shares of $257.0 for Q4 2023, little changed quarter-over-quarter from $257.0 in Q3 2023.

Sunshine Biopharma (SBFM) Treasury Shares (2022 - 2023) Analysis & Trends

Sunshine Biopharma has reported Treasury Shares for 2 years, with the latest figure at $257.0 in Q4 2023.

For the quarter ending Q4 2023, Treasury Shares changed N/A year-over-year to $257.0; the trailing twelve-month figure through Dec 2023 stood at $257.0 (changed N/A YoY), and the FY2023 full-year result was $257.0, changed N/A from the prior year.
Treasury Shares for Q4 2023 stood at $257.0, roughly flat from $257.0 in the prior quarter.
The five-year high for Treasury Shares was $990000.0 in Q2 2022, with the low at -$990000.0 in Q3 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Teva Pharmaceutical Industries	39.72 Bn	35.98 Bn	1.97 Bn	107.00 Mn
2	Zoetis	34.61 Bn	32.67 Bn	1.62 Bn	4.80 Mn
3	United Therapeutics	24.07 Bn	21.91 Bn	648.10 Mn	1.42 Mn
4	Aurora Cannabis	16.98 Bn	16.91 Bn	33.43 Mn	-
5	Neurocrine Biosciences	16.64 Bn	15.32 Bn	800.70 Mn	-
6	Elanco Animal Health	12.19 Bn	11.76 Bn	785.00 Mn	-
7	Alkermes	7.37 Bn	6.86 Bn	-116.06 Mn	17.13 Mn
8	Hims & Hers Health	6.62 Bn	5.87 Bn	396.79 Mn	19.58 Mn
9	Lantheus Holdings	6.47 Bn	5.97 Bn	230.92 Mn	7.24 Mn
10	Sunshine Biopharma	10.94 Mn	4.03 Mn	2.18 Mn	-

Download Data